[On asthma and allergic reactions. Omalizumab: from IgE to anti-IgE].
Ladetzki-Baehs
Kathrin
K
Universität München Fakultät für Chemie und Pharmazie Butenandtstr. 5-13 81377 München.
Dirsch
Verena M
VM
Vollmar
Angelika M
AM
D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E